Lupin Limited has informed the Exchange about Incorporation of a wholly owned subsidiary in Thailand.
LUPIN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Lupin Limited has incorporated a wholly owned subsidiary named 'Lupin (Thailand) Limited' on April 17, 2026. The new entity will operate in the pharmaceutical industry, focused on importing, marketing, promoting, distributing, and selling pharma products in Thailand. It has been set up with a paid-up capital of 3 million Thai Baht (600,000 shares at 5 Baht each), with Lupin holding 100% of the shareholding. The investment was made in cash, and no government or regulatory approvals were required for the incorporation.
This move signals Lupin's strategic push to expand its direct presence in the Southeast Asian market, which could help the company grow its international pharmaceutical footprint over time. For shareholders, it is a positive long-term signal of international expansion, though the capital involved is small and the immediate financial impact on earnings is likely negligible.